Related Experiment Video
Updated: Mar 6, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
16.3K
A Bayesian approach for three-dimensional markerless tumor tracking using kV imaging during lung radiotherapy
Chun-Chien Shieh1, Vincent Caillet1,2, Michelle Dunbar1
1Sydney Medical School, The University of Sydney, NSW 2006, Australia.
Physics in Medicine and Biology
|March 22, 2017
Summary
This study introduces a novel Bayesian approach for markerless tumor tracking in lung radiotherapy, improving accuracy and precision. The method enhances tumor visibility and 3D position estimation, leading to better patient outcomes.
Area of Science:
- Medical Physics
- Radiotherapy Technology
- Image-Guided Therapy
Background:
- Accurate lung tumor motion monitoring is crucial for precise radiotherapy.
- Current kilovoltage (kV) imaging methods struggle with continuous tumor tracking due to poor visibility and 2D to 3D estimation challenges.
- Markerless tumor tracking offers potential for broader access to advanced radiotherapy techniques.
Purpose of the Study:
- To develop and validate a Bayesian approach for markerless tumor tracking in lung radiotherapy.
- To address the limitations of current kV imaging in continuous tumor monitoring and 3D position estimation.
- To demonstrate the clinical feasibility of a novel markerless tumor tracking system.
Main Methods:
- Proposed a Bayesian approach using an extended Kalman filter for markerless tumor tracking.
- Combined a respiratory-correlated model for tumor position prediction with template matching for 2D measurement.
- Validated the method retrospectively on 13 lung cancer patient datasets, comparing against implanted marker ground truths.
Main Results:
- The markerless tumor tracking method demonstrated reduced 3D tracking errors compared to the standard of care.
- Mean, standard deviation, and 95th percentile errors ranged from 1.6-2.9 mm, 0.6-1.5 mm, and 2.6-5.8 mm, respectively.
- Achieved 96.5% of errors with 3D magnitude <5 mm, significantly outperforming the standard of care (84.1%).
Conclusions:
- The study successfully demonstrated the clinical feasibility of 3D markerless tumor tracking in realistic scenarios.
- This novel approach enables more accurate and precise lung radiotherapy using existing infrastructure.
- Future work will focus on clinical implementation and real-time application of the markerless tracking system.

